Sinovac, Gamaleya, Clover need to complete requirements in application for clinical trials — Vergeire

The applications of Sinovac, Gamaleya, and Clover to conduct clinical trials of  their COVID-19 vaccines in the country are still being processed, Health Secretary Maria Rosario Vergeire said on Tuesday.

Interviewed on GMA News’ Unang Balita, Vergeire said the manufacturers need to complete some documents.

“We have Sinovac, meron ho tayong Gamaleya, at meron pa ho tayong isa 'yung Clover na kailangan pa rin hong makakumpleto ng kanilang dokumento,” she said.

According to Vergeire, only Janssen received approval to conduct clinical trial for its COVID-19 vaccines in the country so far.

She added that the Vaccine Expert Panel (VEP) has assigned five sites in the country for the conduct of Janssen’s clinical trial.

Aside from these, other potential vaccine products under the World Health Organization (WHO) Solidarity Trial are also expected to undergo clinical trials in the Philippines.

In December, Department of Science and Technology’s VEP council chairperson and member of the WHO scientific steering committee Dr. Nina Gloriani said the solidarity trial is expected to start this month. — Joviland Rita/RSJ, GMA News